Epstein-Barr virus reactivation and post-transplant lymphoproliferative disorder following letermovir prophylaxis in allogeneic hematopoietic stem cell transplant recipients: A systematic review and meta-analysis.

Prevymis (letermovir) - Merck (MSD)

https://www.asco.org/abstracts-presentations/258819/

Akihiro Miyashita; Abdulrahim Basendwah; Siddharth Kumar; Henri Fero; Fahad Alabbas

Apr 21, 2026